BTMD
biote Corp
1.10$
+1.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.6% | 78.8% | 71.4% | 66.5% | 69.1% | 55.7% | 55.7% | 47.2% | 51.3% | 50.8% | 40.8% | 42.3% | |
| 43.8% | 57.3% | 49.2% | 28.4% | 37.8% | 32.2% | 33.8% | 18.7% | 25.2% | 22.4% | 6.0% | 11.0% | |
| 57.1% | 57.3% | 49.2% | 28.4% | 37.8% | 32.2% | 33.8% | 18.7% | 25.2% | 22.4% | 6.0% | 11.0% | |
| 6.8% | 5.3% | 5.0% | 9.2% | 8.8% | 6.3% | 6.3% | 8.8% | 7.5% | 7.1% | 8.3% | 7.7% | |
| 7.4% | 11.1% | 11.8% | 20.7% | 16.0% | 12.1% | 10.9% | 11.6% | 14.8% | 17.7% | 22.3% | 18.0% | |
| – | 0.0% | 3.5% | 5.9% | 5.4% | 4.8% | 4.7% | 5.6% | 5.2% | 5.4% | 6.6% | 5.7% | |
| 3.6% | 3.2% | 6.8% | 11.7% | 10.5% | 7.7% | 7.3% | 8.1% | 7.2% | 8.2% | 10.1% | 8.4% | |
| 134.2% | 123.5% | 128.0% | 252.5% | 225.3% | 183.5% | 168.8% | 175.2% | 158.8% | 146.8% | 153.9% | 157.2% | |
| 16.8% | 14.3% | 15.0% | 49.8% | 45.9% | 42.1% | 39.3% | 48.2% | 50.6% | 41.8% | 31.7% | 29.6% | |
| 4.4% | 4.2% | 4.2% | 7.2% | 6.6% | 5.5% | 5.5% | 6.5% | 6.1% | 6.4% | 7.7% | 3.8% | |
| 3.8% | 2.7% | 2.6% | 6.2% | 4.3% | 4.8% | 2.7% | 3.7% | 3.9% | 6.3% | 9.3% | 6.5% | |
| 72.1% | 68.7% | 65.7% | 122.6% | 111.2% | 82.7% | 80.9% | 94.0% | 87.2% | 93.7% | 111.7% | 116.4% | |
| -27.1% | -18.9% | -22.1% | -154.3% | -128.7% | -86.6% | -72.9% | -81.2% | -65.4% | -54.4% | -63.0% | -64.7% | |
| -27.1% | -18.9% | -19.6% | -148.2% | -123.2% | -82.0% | -68.4% | -75.8% | -57.3% | -46.0% | -51.7% | -50.1% | |
| 20.7% | 19.4% | 21.6% | 35.6% | 31.9% | 30.5% | 30.0% | 35.3% | 33.0% | 28.6% | 40.4% | 28.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.